![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, September 26, 2010 7:14:07 PM
My post: Doc FG, can you clarify - when you say "too many published articles" are you referring to, PR's or published papers in the commonly accepted medical/research definition (published in a major scientific/medical journal)?
I believe eva is the real deal and am not questioning her, just trying to determine what has been "published" and what has simply been announced.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52968176
Your Response:Presenting at peer reviewed conferences is considered publishing. Such presentations are included in the published proceedings that are sent to attendees, interested parties, and libraries to add to holdings and data bases. NNVC has presented to 3 such conferences on HIV, pandemic threats and influenza. A fourth and most recent report regarding Ebola was published as part of conference proceedings.
For at least 7 conferences, Diwan or Seymour had to submit abstracts for approval from a committee of peers. These also are accepted as peer review of what was presented. Dr. Eva Harris met Dr. Diwan at a peer reviewed conference in Genieva following his presentation.
http://investorshub.advfn.com/boards/replies.aspx?msg=52968176
These are the complete posts, in context. I am clearly asking about publishing in medical or scientific journals and you are saying presenting at peer reviewed conferences is considered publishing.
The question remains (again, a simple yes or no) has there been anything published in any peer reviewed journal about any of the 'cides?
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM